Topic Editors





Applications of Biomedical Technology and Molecular Biological Approach in Brain Diseases, 2nd Edition
Topic Information
Dear Colleagues,
This topic issue is a continuation of the previous successful topic “Applications of Biomedical Technology and Molecular Biological Approach in Brain Diseases”.
This topic includes the assessment of brain diseases and their mechanisms using various biomedical technologies and molecular biological approaches and also includes developments in novel treatments and interventions. In this topic issue, the range of brain diseases comprise neurological diseases and psychiatric disorders. Neurological diseases (e.g., Alzheimer’s disease and Parkinson’s disease) are hot topics for aging societies across many counties, and their treatments and interventions remain unsolved questions. By contrast, patients with psychiatric disorders suffer from chronic symptoms and relapse. Moreover, many psychiatric diseases such as schizophrenia, post-traumatic stress disorder, bipolar disorders, and anxiety disorders cannot be treated using long-term medicinal treatments or psychological interventions.
This topic issue encourages researchers to submit any manuscripts that examine the mechanisms of and/or treatments for any brain diseases, including neurological diseases and psychiatric disorders. The scope of this topic issue includes, but is not limited to, the following technologies and approaches to investigating brain diseases:
- Brain mapping: fMRI, MRI, PET, and CT;
- Molecular and protein labeling: IHC, IF, WB, ELISA, IP, and ICC;
- mRNA labeling: PCR, qRT-PCR, and Fish;
- Others: optogenetics, chemogenetics, and HPLC.
Prof. Dr. Andrew Chih Wei Huang
Dr. Muh-Shi Lin
Dr. Anna Kozłowska
Dr. Bai Chuang Shyu
Prof. Dr. Seong Soo A. An
Topic Editors
Keywords
- drug addiction
- pain
- neuroinflammation
- neurological disorders
- psychiatric disorders
- Alzheimer’s disease
- Parkinson’s disease
- Korsakov’s disease
- anxiety disorders
- post-traumatic stress
- attention deficit hyperactivity disorder
- bipolar disorders
- depression
- schizophrenia
- obsessive–compulsive disorders
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
---|---|---|---|---|---|---|
![]()
Biomedicines
|
3.9 | 5.2 | 2013 | 14.6 Days | CHF 2600 | Submit |
![]()
Brain Sciences
|
2.7 | 4.8 | 2011 | 15.6 Days | CHF 2200 | Submit |
![]()
Cells
|
5.1 | 9.9 | 2012 | 17 Days | CHF 2700 | Submit |
![]()
International Journal of Molecular Sciences
|
4.9 | 8.1 | 2000 | 16.8 Days | CHF 2900 | Submit |
![]()
Journal of Clinical Medicine
|
3.0 | 5.7 | 2012 | 16 Days | CHF 2600 | Submit |
![]()
Neurology International
|
3.2 | 3.7 | 2009 | 26.5 Days | CHF 1600 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.